Nearly 300 volunteers in Long An engage in second-stage trials of Nano Covax
Nearly 300 volunteers in the Mekong Delta province of Long An are set to receive injections of Nano Covax in the second-stage human clinical trials of the COVID-19 vaccine candidate from Vietnam.
The Ministry of Health's leaders inspect necessary procedures before injecting the vaccine to candidates. (Photo: VNA)
Long An (VNA) - Nearly 300volunteers in the Mekong Delta province of Long An are set to receive injectionsof Nano Covax in the second-stage human clinical trials of the COVID-19 vaccinecandidate from Vietnam.
The Ministry of Health began the second phase ofhuman trials at the healthcare centre of Ben Luc district on February 26.
The volunteers, chosen from more than 800 peoplewho registered to take part, consist of two age groups: from 18 to 60 and over60.
They will receive two doses of either thevaccine or the placebo AIPO4, with an interval of 28 days. Each volunteer willbe monitored for 12 months after the first dose.
Volunteers receiving jabs on the morning of February26 will receive the second dose in late March.
The research outcomes of these second-phasetrials will be available in late April.
The second stage human trials of Nano Covax are alsounderway in Hanoi.
Developed by the Nanogen PharmaceuticalBiotechnology JSC and the Hanoi-based Military Medical University, Nano Covaxis Vietnam’s first COVID-19 vaccine to reach the human trial stage.
According to a representative from the university,a total of 560 volunteers, including those with other ailments such ashypertension or diabetes, among others, will participate in the second-stagetrials in both localities.
Lieutenant-General Do Quyet, Director of theMilitary Medical University, said that since the trial is seeing the participationof volunteers with underlying health conditions, relevant authorities are preparedfor all possible scenarios and will ensure the safety of all volunteers.
The first-stage trial of the Nano Covax vaccineshowed that it is likely to be effective against the B117 variant from the UK.
Vietnam is one of 40 countries and territories inthe world to have begun human trials of a COVID-19 vaccine, after successfullyproducing coronavirus test kits early in the pandemic.
The country also has other COVID-19 candidatevaccines being developed: IVAC from the Institute of Vaccines and MedicalBiologicals, VABIOTECH from the Company for Vaccine and Biological ProductionNo 1, and POLYVAC from the Centre for Research and Production of Vaccines andBiologicals./.
The Ministry of Health announced on January 30 that it has approved the use of Astra Zeneca COVID-19 vaccine for pandemic prevention and control in Vietnam.
The Drug Administration of Vietnam under the Ministry of Health has approved the import of the first 204,000 doses of AstraZeneca COVID-19 vaccine of the UK for emergency use.
The first 35 volunteers received injections of the home-grown Nano Covax in the second phase of human trial at the Military Medical University on February 26.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
The Ministry of Health's leaders inspect necessary procedures before injecting the vaccine to candidates. (Photo: VNA) 
